BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24525511)

  • 1. Activating GNAS mutations in parosteal osteosarcoma.
    Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
    Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions.
    Tabareau-Delalande F; Collin C; Gomez-Brouchet A; Decouvelaere AV; Bouvier C; Larousserie F; Marie B; Delfour C; Aubert S; Rosset P; de Muret A; Pagès JC; de Pinieux G
    Mod Pathol; 2013 Jul; 26(7):911-21. PubMed ID: 23370769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
    Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
    Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K; Engels C; Kaiser E; Werner M; Delling G
    Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues.
    Jour G; Oultache A; Sadowska J; Mitchell T; Healey J; Nafa K; Hameed M
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):660-667. PubMed ID: 26574629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
    Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
    Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
    Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL
    Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw.
    Shi RR; Li XF; Zhang R; Chen Y; Li TJ
    Mod Pathol; 2013 Aug; 26(8):1023-31. PubMed ID: 23503642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
    Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions.
    Liang Q; Wei M; Hodge L; Fanburg-Smith JC; Nelson A; Miettinen M; Foss RD; Wang G
    J Mol Diagn; 2011 Mar; 13(2):137-42. PubMed ID: 21354047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on Carter et al's "activating GNAS mutations in parosteal osteosarcoma".
    Tabareau-Delalande F; Collin C; Larousserie F; Bouvier C; Gomez-Brouchet A; Aubert S; Guinebretière JM; Decouvelaere AV; de Muret A; Pagès JC; de Pinieux G
    Am J Surg Pathol; 2015 Jul; 39(7):1010-3. PubMed ID: 25970689
    [No Abstract]   [Full Text] [Related]  

  • 12. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
    Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM
    Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
    Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
    Shin SJ; Lee SJ; Kim SK
    Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.
    Zhadina M; Roszko KL; Geels RES; de Castro LF; Collins MT; Boyce AM
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1482-1490. PubMed ID: 33512531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protuberant fibro-osseous lesions of the temporal bone: two additional case reports.
    Lee M; Song JS; Chun SM; Lee JH; Hong SH; Cho KJ
    Am J Surg Pathol; 2014 Nov; 38(11):1510-5. PubMed ID: 25118809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
    Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
    J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
    Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.